Skip to content

Clinical trials

Hepatitis C trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C Country / region: Russia Clear all

55 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20072
20081
20093
201110
20129
20135
20144
20153
20162
20175
20181
20191
20203
20211
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Terminated2
Active, not recruiting1
Enrolling by invitation1
No longer available1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb11
AbbVie9
Gilead Sciences5
Janssen R&D Ireland4
Janssen-Cilag International NV4
Biocad3
GlaxoSmithKline3
R-Pharm3
Boehringer Ingelheim2
Debiopharm International SA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C55
Hepatitis C, Chronic15
Hepatitis6
Fibrosis4
Acquired Immunodeficiency Syndrome3
Liver Diseases3
Bronchiolitis Obliterans Syndrome2
Coinfection2
HIV Infections2
Hepatitis B2

Trials

Showing 1 to 25 of 55. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.